/Home/Global/Corporate/M&A: Private Equity in Asia-Pacific Region/Milbank LLP
View profile of Milbank LLP
Department profile
Milbank LLP
Department profile | Milbank LLP
Corporate/M&A: Private Equity

Chambers Review

Provided by Chambers

Corporate/M&A: Private Equity - Asia-Pacific Region

3
Band 3

What the Team is Known For

Milbank has an established corporate team based in Singapore, with deep and longstanding expertise relating to Indonesia. The team also handles M&A transactions and private equity work across the wider South-East Asia region, including in Vietnam and the Philippines. In Greater China, the firm has a growing presence in the private equity space, acting for international and regional investors and corporates on investments, LBOs and exits. It is especially active in the healthcare, finance and technology sectors.

Notable practitioners

Jacqueline Chan and David Zemans are key contacts in Singapore, and Andrew Whan and Neeraj Budhwani are key contacts in Hong Kong.

Work Highlights

Provided by Milbank LLP

  • Milbank advised Kimia Farma and Kimia Farma Apotek on the sale of a minority stake in the companies to Silk Road Fund and Indonesia Investment Authority.

Strengths

Provided by Chambers

The team is excellent at working across multiple countries across Asia to execute highly complicated transactions that span commercial, regulatory and tax issues across jurisdictions.

Corporate/M&A: Private Equity respondent
Global

Milbank is my preferred M&A adviser for South-East Asian transactions. Its ability to stay on top of evolving regulatory frameworks but put on a commercial lens to facilitate deals is top-notch.

Corporate/M&A: Private Equity respondent
Global